Ok folks, time to share your trading ideas and other areas of wisdom in this thread.
Provisos re NFP can be included of course
And don’t forget to keep us updated with entry/exit levels
Ok folks, time to share your trading ideas and other areas of wisdom in this thread.
Provisos re NFP can be included of course
And don’t forget to keep us updated with entry/exit levels
Most Popular
Sponsored
MAZE up 180% YOY, but fund trims $3.1M stake post-Phase 2 data. Valuation high, risks loom.
RKT surges 118% on revenue beat, but market shrugs. LADR, FBRT, FLG miss estimates, stocks flat to down.
TYRA's 280% surge continues as HighVista adds shares. Preclinical biotech, no revenue, but strong cash runway.
ZBH revenue up 9.3% but stock drops 10.7%; STE revenue up 7.3%, stock up 4.6%. Mixed results.
Thames Water's £10B rescue deal faces political paralysis risk. Investors fear delays could push it to nationalization.
GPCR up 60% on obesity drug data, but HighVista sells $4.7M amid high valuation.
PGNY beats Q1 estimates on revenue & profit; margin expands despite lower sales volumes. Buy?
Sponsored
Must Read